“Deep tech is not for an elite. It is essential to understand its influence in the development of solutions to improve the lives of millions in vulnerable situations.” Irene Arias Hofman lnkd.in/dgpcinPT

Human-relevant models n Type 2 diabetes provide a more accurate representation of the human disease, enable personalized medicine approaches, and increase the likelihood of successful translation from preclinical studies to clinical practice. Awesome wo…lnkd.in/dFMym5b5

Putting CAR-T therapy to work in autoimmune diseases has caught the attention of several biotech and big pharma groups. lnkd.in/dUCapB9F

Many OVs are grown in Vero, including the three leading OVs plus rotavirus, reovirus, and Zika virus. VYROBIO #virotherapy lnkd.in/dvyqQXVf

New drugs have it possible to live much longer with the disease, and some scientists even see a possible cure down the road. #multiplemyeloma #cancerresearch #biotechnology lnkd.in/ddzd-Jz4

Projeto é uma idealização da Casa Hunter - Associação Brasileira de Doenças Raras, instituição sem fins lucrativos que busca, dentre outras coisas, acolher pacientes com doenças raras e seus familiares. Parabéns pelo brilhante trabalho Antoine Daher! lnkd.in/ddUrEiF9

Investors are still bullish about the sector based on the growth potential seen in artificial intelligence (AI), cell and gene therapy (CGT), and other new technologies. lnkd.in/es2A-8Xv

The gene therapy works by infusing trillions of harmless viruses in single treatment that has been genetically modified to ferry a gene to patients' muscles. At VYROBIO we are developing a novel class of viral vector to deliver ge…lnkd.in/eRJjf_7g lnkd.in/eYqec-wW

The cost makes Sarepta’s treatment, called Elevidys, among the most expensive medicines in the world. But company executives said they don’t expect significant insurer pushback. lnkd.in/d9Y44kjB

Researchers used three types of 3-D laboratory models — spheroids, organoids and mouse models — created from human ovarian cancer cells. Rafael Dariolli Bonds Biosystems lnkd.in/d8dcsizM

Induced pluripotent stem cells (iPSCs) producing pancreatic β-cells -- one step closer to the clinic. Vertex Pharmaceuticals #stemcellresearch #biotechnology #diabetes lnkd.in/dHHxtsZF

We may be on the cusp of an era of astonishing innovation — the limits of which aren’t even clear yet. lnkd.in/d_2MyRyy

“The use of Phase 0 clinical trials in neuro-oncology has never been more critical.” Nader Sanai Ivy Brain Tumor Center VYROBIO lnkd.in/dvQSyG2N

Recent research from McKinsey & Company shows that, over the past decade, the average time to take a new medication from candidate nomination for preclinical testing to first-in-human trials has been about 26 months. VYROBIO lnkd.in/d49pjYq5

Interesting project at the intersection of engineering and biology — a microfluidics cell and gene therapy manufacturing platform. lnkd.in/d4zTgVDw

Vesper Ventures has the ability to identify and invest in promising biotech startups with strong growth potential and innovative technologies. 🚀 #biotechnology #venturecapital #LATAM lnkd.in/ddUsxgEK

Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.  lnkd.in/dXAmnw8W

Great discussion from Last Call on the therapeutic benefits of psychedelic therapy. Thank you, @blakemycoskie for your philanthropy, and for believing and investing in us and our mission to enable everyone everywhere with mental health disorders to live a more fulfilled

National Science Scholarship (PhD) a-star.edu.sg/Scholarships/f…

Fantastic presentation on viral approaches to treating #glioblastoma by Dr. Eva Galanis ⁦Mayo Clinic⁩ & ⁦National Brain Tumor Society⁩ Emeritus Board Member today at #SNO2023